Pharmaceutical Products-Open-House Biologika Discount Contracts 2025-19-Adalimumab. The Aim Is To Conclude Pharmaceutical Discounts According To Section 130A (8) Sgb V To The Active Ingredient Adalimumab As Part Of An Open House Procedure.
We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.
